Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

doi:10.1371/journal.ppat.1005334

Review

. 2016 Apr 26;12(4):e1005334.

doi: 10.1371/journal.ppat.1005334. eCollection 2016 Apr.

Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

Sasirekha Ramani¹, Mary K Estes^{1

2}, Robert L Atmar^{1

2}

Affiliations

¹ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
² Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.

PMID: 27115358
PMCID: PMC4846004
DOI: 10.1371/journal.ppat.1005334

Review

Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

Sasirekha Ramani et al. PLoS Pathog. 2016.

. 2016 Apr 26;12(4):e1005334.

doi: 10.1371/journal.ppat.1005334. eCollection 2016 Apr.

Authors

Sasirekha Ramani¹, Mary K Estes^{1

2}, Robert L Atmar^{1

2}

Affiliations

¹ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
² Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.

PMID: 27115358
PMCID: PMC4846004
DOI: 10.1371/journal.ppat.1005334

No abstract available

PubMed Disclaimer

Conflict of interest statement

I have read the journal's policy and have the following conflicts: MKE is named as an inventor on patents related to cloning of the Norwalk virus genome and has served as a consultant to Takeda Vaccines, Inc. RLA has received research grant funding from and is an unpaid consultant to Takeda Vaccines, Inc. This does not alter our adherence to all PLOS policies on sharing data and materials.

Cited by

The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.
Lopman BA, Steele D, Kirkwood CD, Parashar UD. Lopman BA, et al. PLoS Med. 2016 Apr 26;13(4):e1001999. doi: 10.1371/journal.pmed.1001999. eCollection 2016 Apr. PLoS Med. 2016. PMID: 27115709 Free PMC article. Review.
Identification of a First Human Norovirus CD8⁺ T Cell Epitope Restricted to HLA-A^*0201 Allele.
Malm M, Vesikari T, Blazevic V. Malm M, et al. Front Immunol. 2018 Nov 27;9:2782. doi: 10.3389/fimmu.2018.02782. eCollection 2018. Front Immunol. 2018. PMID: 30542352 Free PMC article.
Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study.
O'Reilly KM, Sandman F, Allen D, Jarvis CI, Gimma A, Douglas A, Larkin L, Wong KLM, Baguelin M, Baric RS, Lindesmith LC, Goldstein RA, Breuer J, Edmunds WJ. O'Reilly KM, et al. BMC Med. 2021 Nov 9;19(1):299. doi: 10.1186/s12916-021-02153-8. BMC Med. 2021. PMID: 34753508 Free PMC article.
Glycan Recognition in Human Norovirus Infections.
Tenge VR, Hu L, Prasad BVV, Larson G, Atmar RL, Estes MK, Ramani S. Tenge VR, et al. Viruses. 2021 Oct 14;13(10):2066. doi: 10.3390/v13102066. Viruses. 2021. PMID: 34696500 Free PMC article. Review.
GII.4 Human Norovirus: Surveying the Antigenic Landscape.
Mallory ML, Lindesmith LC, Graham RL, Baric RS. Mallory ML, et al. Viruses. 2019 Feb 20;11(2):177. doi: 10.3390/v11020177. Viruses. 2019. PMID: 30791623 Free PMC article. Review.

See all "Cited by" articles

References

1. Ramani S, Atmar RL, Estes MK. Epidemiology of human noroviruses and updates on vaccine development. Current opinion in gastroenterology. 2014;30(1):25–33. Epub 2013/11/16. 10.1097/MOG.0000000000000022 - DOI - PMC - PubMed
1. Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine. 2012;30(49):7097–104. Epub 2012/10/03. 10.1016/j.vaccine.2012.09.040 - DOI - PMC - PubMed
1. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, et al. Norovirus vaccine against experimental human Norwalk Virus illness. The New England journal of medicine. 2011;365(23):2178–87. Epub 2011/12/14. 10.1056/NEJMoa1101245 - DOI - PMC - PubMed
1. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. The New England journal of medicine. 1977;297(2):86–9. Epub 1977/07/14. 10.1056/NEJM197707142970204 . - DOI - PubMed
1. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. The Journal of infectious diseases. 2002;185(9):1335–7. 10.1086/339883 . - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Ramani S, Atmar RL, Estes MK. Epidemiology of human noroviruses and updates on vaccine development. Current opinion in gastroenterology. 2014;30(1):25–33. Epub 2013/11/16. 10.1097/MOG.0000000000000022 - DOI - PMC - PubMed

[2] Ramani S, Atmar RL, Estes MK. Epidemiology of human noroviruses and updates on vaccine development. Current opinion in gastroenterology. 2014;30(1):25–33. Epub 2013/11/16. 10.1097/MOG.0000000000000022 - DOI - PMC - PubMed

[3] Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine. 2012;30(49):7097–104. Epub 2012/10/03. 10.1016/j.vaccine.2012.09.040 - DOI - PMC - PubMed

[4] Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine. 2012;30(49):7097–104. Epub 2012/10/03. 10.1016/j.vaccine.2012.09.040 - DOI - PMC - PubMed

[5] Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, et al. Norovirus vaccine against experimental human Norwalk Virus illness. The New England journal of medicine. 2011;365(23):2178–87. Epub 2011/12/14. 10.1056/NEJMoa1101245 - DOI - PMC - PubMed

[6] Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, et al. Norovirus vaccine against experimental human Norwalk Virus illness. The New England journal of medicine. 2011;365(23):2178–87. Epub 2011/12/14. 10.1056/NEJMoa1101245 - DOI - PMC - PubMed

[7] Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. The New England journal of medicine. 1977;297(2):86–9. Epub 1977/07/14. 10.1056/NEJM197707142970204 . - DOI - PubMed

[8] Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. The New England journal of medicine. 1977;297(2):86–9. Epub 1977/07/14. 10.1056/NEJM197707142970204 . - DOI - PubMed

[9] Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. The Journal of infectious diseases. 2002;185(9):1335–7. 10.1086/339883 . - DOI - PubMed

[10] Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. The Journal of infectious diseases. 2002;185(9):1335–7. 10.1086/339883 . - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

Affiliations

Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical